Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: study protocol of the randomized phase II DURATION trial - Kuon, Jonas; Hommertgen, Adriane; Krisam, Johannes; Lasitschka, Felix; Stenzinger, Albrecht; Blasi, Miriam; Bozorgmehr, Farastuk; Maenz, Martin; Kieser, Meinhard; Schneider, Marc; Thomas, Michael (Trials, 2020)
Gesehen am 03.06.2020